Decreased CSF cytokine levels in α7 KO mice. by Feng Chi (170688)

ATXN3 depletion decreases PNKP’s 3’-phosphatase activity. by Arpita Chatterjee (529752)

Systemic TUDCA administraton decreases photoreceptor cell loss in RD. by Dimosthenis Mantopoulos (343471)

PGRN decreased Dectin-2 expression on the surface of macrophages and neutrophils. by Jiayu Liu (3951515)

TNFα significantly decreases PRLR immunoreactivity in the outer root sheath of hair follicles. by Ewan A. Langan (405804)

“…<p>(A) PRLR IR in the outer root sheath of control hair follicles (black arrows) was reduced in comparison PRLR IR after treatment with TNFα at concentrations of (B) 0.5 ng/ml and (C) 5 ng/ml. …”

Decreases in locomotor responses to a single METH injection in <i>Ptprz</i>-KO mice. by Akihiro Fujikawa (122649)

Cilostazol decreases OC formation and bone resorption induced by RANKL. by Ke Ke (583325)

PF treatment decreases the levels of IL-1β(A) and TNFα(B) in plasma. by Ruo-Bing Guo (298949)

Albumin degradation in podocytes decreased with lysosome inhibition, but not proteasome inhibition. by John M. Carson (577297)

Lethal toxin decreases IL-22 production in human ILCs. by Sudarshan Seshadri (370894)

Validation of a New Scoring Scale for Behavioral Assessment of L‑Dopa-Induced Dyskinesia in the Rat: A New Tool for Early Decision-Making in Drug Development by Simon Loiodice (4715610)

“…The rating scale was sensitive enough to highlight a dose-dependent amantadine-mediated decrease (about 2.2-fold) in LID score. …”

Fig 5 - by Te-Hsing Hsu (16973374)

Probucol prevents 3-NP-induced decreases in body weight. by Dirleise Colle (422124)

h-GAAP Decreases Cell Susceptibility to Extrinsic Apoptosis Pathways by Caroline Gubser (24818)

Anandamide decreases locomotor activity and rearing in small open field. by Adriaan W. Bruijnzeel (2605954)

Pre-treatment of striatal slices by DCF decreases HDA uptake (a) and dopamine content (b) by Elisaveta Milusheva (45672)

Basal IKK activity is decreased in cells lacking IRE1. by Arvin B. Tam (124164)

PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

“…Following P binder discontinuation, the long interdialytic interval mean ± SE serum P numerically increased from 5.8 ± 0.4 to 7.0 ± 0.5 mg/dl (p = 0.06). On patiromer, P decreased from 7.0 ± 0.5 to 6.2 ± 0.5 mg/dl (p = 0.04). …”

Uric acid treatment decreases glucose-stimulated insulin secretion. by Lu Jia (295253)

Acute JMV2959 treatment decreases alcohol preference in rats. by Petra Suchankova (400313)

“…<p>(A) Acute administration of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) decreases the alcohol preference compared to vehicle at 1 hour time interval in rats voluntarily consuming alcohol for two and five months before the treatment. …”